News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
681,906 Results
Type
Article (67316)
Company Profile (457)
Press Release (614133)
Section
Business (181928)
Career Advice (3213)
Deals (32231)
Drug Delivery (109)
Drug Development (82861)
Employer Resources (177)
FDA (15780)
Job Trends (14434)
News (319980)
Policy (31005)
Tag
Academia (2926)
Alliances (48552)
Alzheimer's disease (1349)
Approvals (15695)
Artificial intelligence (154)
Bankruptcy (304)
Best Places to Work (11500)
Biotechnology (341)
Breast cancer (188)
Cancer (1383)
Cardiovascular disease (114)
Career advice (2709)
CAR-T (104)
Cell therapy (309)
Clinical research (65418)
Collaboration (472)
Compensation (235)
COVID-19 (2681)
C-suite (115)
Data (1384)
Diabetes (170)
Diagnostics (6072)
Earnings (66450)
Employer resources (155)
Events (109134)
Executive appointments (361)
FDA (16417)
Funding (429)
Gene therapy (219)
GLP-1 (656)
Government (4547)
Healthcare (19094)
Infectious disease (2762)
Inflammatory bowel disease (122)
Interviews (623)
IPO (15230)
Job creations (3361)
Job search strategy (2236)
Layoffs (434)
Legal (6633)
Lung cancer (199)
Manufacturing (209)
Medical device (12488)
Medtech (12492)
Mergers & acquisitions (17168)
Metabolic disorders (469)
Neuroscience (1687)
NextGen Class of 2024 (6716)
Non-profit (4880)
Northern California (1637)
Obesity (270)
Opinion (239)
Patents (115)
People (53326)
Phase I (20493)
Phase II (28768)
Phase III (21410)
Pipeline (508)
Postmarket research (2762)
Preclinical (9233)
Radiopharmaceuticals (256)
Rare diseases (276)
Real estate (5811)
Regulatory (21271)
Research institute (2616)
Resumes & cover letters (510)
Southern California (1414)
Startups (3508)
United States (14845)
Vaccines (598)
Weight loss (205)
Date
Today (127)
Last 7 days (701)
Last 30 days (2942)
Last 365 days (36114)
2024 (35086)
2023 (40543)
2022 (51658)
2021 (56063)
2020 (54167)
2019 (47128)
2018 (35694)
2017 (33050)
2016 (32921)
2015 (38206)
2014 (30820)
2013 (26686)
2012 (27572)
2011 (27998)
2010 (26311)
Location
Africa (979)
Arizona (150)
Asia (40485)
Australia (7326)
California (3699)
Canada (1374)
China (293)
Colorado (167)
Connecticut (178)
Europe (94318)
Florida (506)
Georgia (132)
Illinois (393)
Indiana (200)
Maryland (614)
Massachusetts (2991)
Michigan (170)
Minnesota (281)
New Jersey (1056)
New York (1050)
North Carolina (779)
Northern California (1637)
Ohio (145)
Pennsylvania (892)
South America (1281)
Southern California (1414)
Texas (527)
Utah (103)
Washington State (399)
681,906 Results for "the multiple myeloma research foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma
December 5, 2024
·
3 min read
Business
Multiple Myeloma Research Foundation (MMRF) Presents New Data from Multiple Myeloma Research Programs at the 21st International Myeloma Society Annual Meeting
September 25, 2024
·
5 min read
CAR-T
Gilead, Arcellx Tout Best-in-Class Potential for CAR T Therapy in Multiple Myeloma
Truist Securities analyst Asthika Goonewardene in an investor note said data for anito-cel—particularly its safety profile—will help differentiate the CAR T therapy from Legend Biotech and J&J’s entrenched Carvykti in relapsed and refractory multiple myeloma.
November 6, 2024
·
2 min read
·
Tristan Manalac
Cancer
GSK Builds Case for Blenrep with Multiple Myeloma OS Data That Bests J&J’s Darzalex
GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster potential for the antibody-drug conjugate.
November 14, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Multiple Myeloma Research Foundation (MMRF) Announces New Publication on CoMMpass℠ Study in Nature Genetics Defining Distinct Subtypes of Multiple Myeloma and High-Risk Genetic Markers
August 19, 2024
·
4 min read
Biotech Bay
Mission Bio Announces Launch of First Single-Cell Multiple Myeloma Multiomics Solution Aimed to Transform Translational Research and Therapy Development
Mission Bio today announced the launch of the Tapestri® Single-cell Multiple Myeloma Multiomics Solution.
June 4, 2024
·
5 min read
Multiple Myeloma Antibody Combinations Clinical Trials Insight
The treatment landscape for multiple myeloma ailment is a rapidly evolving field with ongoing research and clinical trials aimed at better understanding these conditions and developing effective therapies.
May 22, 2024
·
4 min read
Approvals
Sanofi Secures First-Line Nod for Sarclisa in Multiple Myeloma, Tees Up Competition With J&J
With Friday’s approval, Sanofi’s anti-CD38 antibody Sarclisa will go head-to-head with the first such therapy for multiple myeloma, Johnson & Johnson’s Darzalex, which raked in nearly $10 billion last year.
September 23, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Mission Bio Partners With Top Researchers From University of Miami to Accelerate Early Relapse Detection & Treatment Selection of Multiple Myeloma Patients
December 2, 2024
·
3 min read
Pharm Country
The Multiple Myeloma Research Foundation Announces $21M Grant Program to Support Multicenter Translational Research Networks
The Multiple Myeloma Research Foundation announced the recipients of three $7 million MMRF Myeloma Accelerator Challenge Program Grants totaling $21 million.
November 2, 2023
·
5 min read
1 of 68,191
Next
